Cancer Family
Encapsulated Neoplasm
CI-CAN-00000014Explore in graph →
- NCIt
- C36035
Loading cancer entity…
Cancer Family
CI-CAN-00000014Explore in graph →
Variants & evidence
7 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Cancer | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| GNAS R201H1 | ||||||||
| Radioactive Iodine | Thyroid Gland Follicular CarcinomaALIAS | Predictive | C | Supports Sensitivity Response | 3 | accepted | EID3045A 79 year old patient with prior 5-year history of Graves' disease presented with follicular thyroid carcinoma. Two mutations NRAS p.Q61K and GNAS p.R201H were detected. The thyroid cancer manifested … (full text at CIViC) PMID 26788326 · Lu et al., 2016 · Open in CIViC | civic |
| HRAS Q611 | ||||||||
| (prognostic) | Thyroid Gland Follicular CarcinomaALIAS | Prognostic | B | Does Not Support Poor Outcome | 2 | accepted | EID6960Follicular thyroid cancers harboring RAS mutations have limited aggressiveness in the absence of TERT mutations. 2/2 follicular thyroid cancer patients with co-mutations in NRAS (10 Q61R and 1 Q61K) o… (full text at CIViC) PMID 25448848 · Muzza et al., 2015 · Open in CIViC | civic |
| MEN1 FRAMESHIFT TRUNCATION1 | ||||||||
| (diagnostic) | Thyroid Gland Oncocytic CarcinomaALIAS | Diagnostic | C | Supports Positive | 2 | accepted | EID1695Two patients diagnosed with oncocytic thyroid carcinoma (hurthle cell thyroid carcinoma) were evaluated for MEN1 mutations. One tumor showed 592-end deletion of MEN1 and the other showed a 521 frames… (full text at CIViC) PMID 25625803 · Kasaian et al., 2015 · Open in CIViC | civic |
| NRAS Q613 | ||||||||
| (prognostic) | Thyroid Gland Follicular CarcinomaALIAS | Prognostic | B | Supports N/A | 3 | accepted | EID497In patients with follicular thyroid carcinoma, those with mutations in NRAS at codon 61 did not have significantly different overall survival than patients with wild-type NRAS (p=0.36). PMID 22650231 · Fukahori et al., 2012 · Open in CIViC | civic |
| 〃 | Thyroid Gland Follicular CarcinomaALIAS | Prognostic | B | Does Not Support Poor Outcome | 2 | accepted | EID6959Follicular thyroid cancers harboring RAS mutations have limited aggressiveness in the absence of TERT mutations. 2/2 follicular thyroid cancer patients with co-mutations in NRAS (10 Q61R and 1 Q61K) o… (full text at CIViC) PMID 25448848 · Muzza et al., 2015 · Open in CIViC | civic |
| 〃 | Thyroid Gland Follicular CarcinomaALIAS | |||||||
| PPARG Fusion1 | ||||||||
| (diagnostic) | Thyroid Gland Follicular CarcinomaALIAS | Diagnostic | B | Supports Positive | 3 | accepted | EID498PAX8–PPARG gene fusions were found in 12/33 follicular thyroid carcinoma tumor samples, but were rarely found in thyroid Hürthle cell tumors. PMID 12727991 · Nikiforova et al., 2003 · Open in CIViC | civic |
Data updated 2 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.
| Prognostic |
| B |
| Supports Poor Outcome |
| 2 |
| submitted |
EID7104Retrospective analysis of thyroid carcinoma patients from a single institution identified 33/58 patients with follicular carcinomas had any RAS mutations (NRAS, KRAS, or HRAS at codons 12 or 61), 22 o… (full text at CIViC) PMID 22650231 · Fukahori et al., 2012 · Open in CIViC |
| civic |